Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-01-19-Speech-3-230-500"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110119.20.3-230-500"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
".
On 19 January 2011, the European Parliament adopted a directive on the application of patients’ rights in cross-border healthcare, which is aimed at simplifying the rules governing treatment abroad. I am pleased to note that the European Parliament, as colegislator, played a key role in formulating clear provisions that benefit patients
with regard to the reimbursement of the costs of medical care in other countries. Provisions concerning cross-border healthcare are all the more important as they affect every citizen of the European Union. The new directive guarantees the mutual recognition of prescriptions and easier access to information on treatment abroad, as well as increasing the scope of treatment for individuals suffering from rare diseases and providing more opportunity for disabled people to obtain higher rates of reimbursement of the costs of medical care. The European Parliament is also to play a role in establishing national contact points in each Member State, which will provide information on all aspects of treatment abroad. These points will cooperate closely with each other. Finally, I would like to say that there is an urgent need for the directive we have adopted, since the legislation on treatment abroad currently in force is unclear and overcomplicated, and it is imperative to simplify such matters for the sake of every EU Member State."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples